"EFFECT OF 5-LIPOXYGENASE INHIBITOR, VIA-2291, ON EPICARDIAL FAT VOLUME IN PATIENTS WITH RECENT ACUTE CORONARY SYNDROME" by Shone Almeida

Selected Works of Shone Almeida, MD

Follow Contact

Article

EFFECT OF 5-LIPOXYGENASE INHIBITOR, VIA-2291, ON EPICARDIAL FAT VOLUME IN PATIENTS WITH RECENT ACUTE CORONARY SYNDROME

Journal of the American College of Cardiology (2018)

Shone Almeida, Los Angeles Biomedical Research Institute
Matthew Budhoff, Los Angeles Biomedical Research Institute

Link

Disciplines

Medicine and Health Sciences,
Cardiology and
Internal Medicine

Publication Date

March 10, 2018

DOI

10.1016/S0735-1097(18)32134-X

Citation Information

Shone Almeida and Matthew Budhoff. "EFFECT OF 5-LIPOXYGENASE INHIBITOR, VIA-2291, ON EPICARDIAL FAT VOLUME IN PATIENTS WITH RECENT ACUTE CORONARY SYNDROME" Journal of the American College of Cardiology Vol. 71 Iss. 11 (2018)
Available at: http://works.bepress.com/shone-almeida/17/